Mutations in the coding sequence (CDS) of TP53, encoding the p53 tumor suppressor, are found in ~75% of LFS families; these TP53 mutants produce mutant p53 proteins that lack most or all tumor-suppressive functions and often confer oncogenic properties5–7. Here, TP53 is linked to neoplasm.